FDA
-
-
-
-
-
-
-
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved
-
-
-
-
-
-
-
IceCure Medical receives China patent allowance for cryogen flow control
-
-
-
-
-
-
-
IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival
-
-
-
-
-
-
-
IceCure receives Israel approval for XSense cryoablation system
-
-
-
-
-
-
-
IceCure Announces Record Date for Rights Offering for Up to $10 Million
-
-
-
-
-
-
-
IceCure Medical Ltd (ICCM) Announces Positive FDA Development
-
-
-
-
-
-
-
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense⢠Cryoablation System in Israel
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

